Contraception Research Centers Program (U54 Clinical Trial Optional)
The purpose of this funding opportunity announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods that are acceptable to women and men through the formation of a Contraceptive Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success, and also behavioral and social science research projects to study contraceptive use and non-use of marketed products or products in clinical development. Contraception Development Research Projects of high program priority include non-hormonal multipurpose prevention technology (MPT) products (e.g., implants, films, transdermal) with both contraceptive and anti-infective properties. Additional details can be found on www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: RFA-HD-19-023, then clicking on the opportunity number.
• Funding Opportunity #: RFA-HD-19-023
• Open Date: 13 January 2019
• Letter of Intent Due: 13 February 2019
• Application Due: 13 February 2019 by 5:00 p.m. local time of applicant organization
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
The purpose of this funding opportunity announcement (FOA) is to solicit applications for HIV Prevention Clinical Trials Network Leadership and Operations Center (LOC). The National Institute of Allergy and Infectious Diseases (NIAID) and NIH have advanced understanding of disease mechanisms and used basic science to create opportunities for the discovery, development, and clinical evaluation of novel prevention and treatment strategies. In order to reduce HIV incidence at a population level, research must focus on advancing a range of products and strategies to meet the needs of populations vulnerable to HIV infection. These include research priority areas like ARV-based HIV prevention products and delivery methods, MPTs with anti-infective and contraceptive properties, as well as integrated biomedical and sociobehavioral prevention strategies. Only AIDS applications will be accepted. Additional details can be found on www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: RFA-AI-19-005, then clicking on the opportunity number.
• Funding Opportunity #: RFA-AI-19-005
• Open Date: 1 July 2019
• Letter of Intent Due: 1 July 2019
• Application Due: 1 August 2019 by 5:00 p.m. local time of applicant organization